MetaCap

UL Solutions Cash Flow Statement

NYSE: ULSHealth CarePrecision InstrumentsUSD

69.99-0.66 (-0.93%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

UL Solutions free cash flow

In fiscal 2025, UL Solutions generated $600.0 million of operating cash flow and spent $197.0 million on capital expenditures. That left free cash flow of $403.0 million, a free-cash-flow margin of 13.2% of revenue. Free cash flow was up 40.4% from the prior year's $287.0 million.

UL Solutions returned $104.0 million to shareholders through dividends, equal to 26% of free cash flow. Free cash flow covered dividend payments 3.9 times.

Summary generated from market data by MetaCap's automated system. Methodology

UL Solutions cash flow statement (annual)

UL Solutions annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31
Net Income345.00M345.00M276.00M309.00M
Net Income growth (YoY)0.00%+25.00%-10.68%—
Depreciation & Amortization188.00M172.00M154.00M135.00M
Stock-Based Compensation47.00M23.00M00
Change in Working Capital35.00M-11.00M-21.00M-118.00M
Operating Cash Flow600.00M524.00M467.00M372.00M
Capital Expenditures-197.00M-237.00M-215.00M-164.00M
Investing Cash Flow-204.00M-234.00M-175.00M-238.00M
Dividends Paid-104.00M-100.00M-680.00M-1.60B
Debt Issued792.00M181.00M440.00M700.00M
Debt Repaid-1.04B-346.00M-30.00M-200.00M
Financing Cash Flow-396.00M-284.00M-294.00M-1.12B
Net Change in Cash-3.00M-17.00M-7.00M-1.01B
Free Cash Flow403.00M287.00M252.00M208.00M

This table shows 4 annual periods of UL Solutions's cash flow statement, from FY 2025 back to FY 2022, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ULS's reporting calendar. What is a cash flow statement?

More financial data